Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaochun Han

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Medicinal Chemistry|April 10, 2014
Structure-based drug design of RN486, a potent and selective Bruton's tyrosine kinase (BTK) inhibitor, for the treatment of rheumatoid arthritisYan Lou, Xiaochun Han, Andreas Kuglstatter, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2008
Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptaseZachary K Sweeney, James P Dunn, Yu Li, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical propertiesLeyi Gong, Xiaochun Han, Tania Silva, et al.
Journal of Medicinal Chemistry|October 3, 2013
Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domainAndrew F Donnell, Christophe Michoud, Kenneth C Rupert, et al.
Journal of Medicinal Chemistry|October 8, 2013
Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domainRobert F Kester, Andrew F Donnell, Yan Lou, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Medicinal Chemistry|April 10, 2014
Structure-based drug design of RN486, a potent and selective Bruton's tyrosine kinase (BTK) inhibitor, for the treatment of rheumatoid arthritisYan Lou, Xiaochun Han, Andreas Kuglstatter, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2008
Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptaseZachary K Sweeney, James P Dunn, Yu Li, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical propertiesLeyi Gong, Xiaochun Han, Tania Silva, et al.
Journal of Medicinal Chemistry|October 3, 2013
Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domainAndrew F Donnell, Christophe Michoud, Kenneth C Rupert, et al.
Journal of Medicinal Chemistry|October 8, 2013
Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domainRobert F Kester, Andrew F Donnell, Yan Lou, et al.
Pageof 5